期刊文献+

LncRNA SOX2OT、miR-211在非小细胞肺癌患者组织中的表达及其预后相关性 被引量:2

Expression of LncRNA SOX2OT and miR-211 in non-small cell lung cancer and their correlation with prognosis
原文传递
导出
摘要 目的:检测长链非编码RNA SOX2重叠转录本(LncRNA SOX2OT)、微小RNA-211(miR-211)在非小细胞肺癌(NSCLC)患者组织中的表达水平,并探究其预后相关性。方法:选取2014年1月至2016年1月于本院住院治疗的85例NSCLC患者癌组织作为NSCLC组,选取其相应癌旁正常组织作为对照组。采用实时荧光定量PCR(qRT-PCR)法检测组织LncRNA SOX2OT、miR-211水平;Pearson法分析LncRNA SOX2OT、miR-211的相关性;分析NSCLC组织LncRNA SOX2OT、miR-211水平与患者临床病理特征的关系;KaplanMeier法分析NSCLC组织LncRNA SOX2OT、miR-211表达与患者生存率的关系;多因素Cox回归分析影响NSCLC患者预后的因素。结果:NSCLC组LncRNA SOX2OT表达水平高于对照组,miR-211表达水平低于对照组,差异具有统计学意义(P<0.05)。NSCLC患者癌组织中LncRNA SOX2OT与miR-211表达水平呈负相关(r=-0.501,P<0.05)。LncRNA SOX2OT、miR-211表达与年龄、性别无关,差异无统计学意义(P>0.05);与组织学类型、淋巴结转移、分化程度、TNM分期有关,差异有统计学意义(P<0.05)。LncRNA SOX2OT低表达组5年内存活率(85.00%)高于高表达组(24.44%);miR-211低表达组5年内存活率(24.39%)低于高表达组(79.55%),差异有统计学意义(χ^(2)=31.169、25.915,P<0.05)。LncRNA SOX2OT高表达、miR-211低表达、TNMⅢ+Ⅳ期是影响NSCLC患者不良预后的危险因素(P<0.05)。结论:LncRNA SOX2OT、miR-211可能存在协同作用,共同参与NSCLC的发生、发展,两者对NSCLC患者的病情评价及治疗可能有重要意义。 Objective:To detect the expression levels of long non-coding RNA SOX2 overlapping transcript(LncRNA SOX2OT)and microRNA-211(miR-211)in non-small cell lung cancer(NSCLC)tissues,and to explore their prognostic relevance.Methods:The cancer tissue from 85 cases of NSCLC patients who were hospitalized in our hospital from January 2014 to January 2016 were selected as NSCLC group,and their corresponding normal tissues were selected as control group.Real-time fluorescence quantitative PCR(q RT-PCR)was used to detected the levels of LncRNA SOX2OT and miR-211;Pearson method was used to analyze the correlation between LncRNA SOX2OT and miR-211;the relationship between the levels of LncRNA SOX2OT and miR-211 in NSCLC tissues and clinicopathological characteristics was analyzed;Kaplan-Meier method was used to analyze the relationship between the expression of LncRNA SOX2OT and miR-211 and the survival rate of NSCLC tissue;multivariate Cox regression analysis was used to analyze the prognostic factors of NSCLC patients.Results:The expression level of LncRNA SOX2OT in the NSCLC group was higher than that in the control group,and the expression level of miR-211 was lower than that in the control group(P<0.05).There was a negative correlation between the expression levels of LncRNA SOX2OT and miR-211 in cancer tissues of NSCLC patients(r=-0.501,P<0.05).The expression of LncRNA SOX2OT and miR-211 was not related to age and gender(P>0.05);but was related to histological type,lymph node metastasis,differentiation degree and TNM stage(P<0.05).The 5-year survival rate of LncRNA SOX2OT low expression group(85.00%)was higher than that of high expression group(24.44%);the 5-year survival rate of miR-211 low expression group(24.39%)was lower than that of high expression group(79.55%),the differences were statistically significant(χ^(2)=31.169,25.915,P<0.05).High expression of LncRNA SOX2OT,low expression of miR-211 and TNM stageⅢ+Ⅳwere risk factors for poor prognosis of NSCLC patients(P<0.05).Conclusion:LncRNA SOX2OT and miR-211 may have synergistic effect,and play a role in the occurrence and development of NSCLC.They may be of great significance in the evaluation and treatment of NSCLC patients.
作者 陈浩舟 白冰 武愫斌 CHEN Haozhou;BAI Bing;WU Subin(Department of Thoracic Surgery,Shangluo Central Hospital,Shangluo 726000,China)
出处 《现代医学》 2021年第8期919-925,共7页 Modern Medical Journal
关键词 非小细胞肺癌 长链非编码RNA SOX2重叠转录本 微小RNA-211 non small cell lung cancer long non-coding RNA SOX2 overlapping transcript microRNA-211
  • 引文网络
  • 相关文献

参考文献8

二级参考文献48

  • 1Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer[J]. J Thorac Oncol, 2015, 10(7): 900-1003.
  • 2Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer[J]. J Thorac Oncol, 2015, 10(12): 1675-84.
  • 3Eberhardt WE, MitchelI A, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cance r[J]. J Thorac Oncol, 2015, 10(11): 1515-22.
  • 4Rami-Porta R, Bolejack V, Giroux DJ, et al. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer[J]. J Thorac Oncol, 2014, 9(ll): 1618-24.
  • 5Wittekind C, Compton C, Brierley J, et al. TNM Supplement A Commentary on Uniform Use 4th Ed[M]. Oxford: Wiley- Blackwell, 2012: 6.
  • 6Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ ATS/ERS classification of lung adenocarcinoma: prognostic subgroups andimplications for further revision of staging based on analysis of 514 stage I cases[J]. Mod Pathol, 2011, 24(5): 653-64.
  • 7Tsutani Y, Miyata Y, Nakayama H, et al. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study[J]. J Thorac Cardiovasc Surg, 2012, 143(3): 607-12.
  • 8Maeyashiki T, Suzuki K, Hattori A, et al. The size of consolidation on thin-section computed tomographyis a better predictor of survival than the maximum tumourdimension in resectable lung cancer[J]. Eur J Cardiothorac Surg, 2013, 43(5): 915-8.
  • 9Edge SB, Byrd DR, Compton CC, et al. Cancer Staging Manual 7th Ed[M]. New York: Springer, 2010: 253-70.
  • 10Goldstraw P. Staging manual in thoracic oncology[M]. Orange Park, FL: Editorial Rx Press, 2009: 32-3.

共引文献238

同被引文献28

引证文献2

;
使用帮助 返回顶部